C
Charles V. Pollack
Researcher at Thomas Jefferson University
Publications - 321
Citations - 20718
Charles V. Pollack is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Myocardial infarction & Emergency department. The author has an hindex of 72, co-authored 315 publications receiving 19261 citations. Previous affiliations of Charles V. Pollack include Pennsylvania Hospital & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Idarucizumab for Dabigatran Reversal
Charles V. Pollack,Paul A. Reilly,John W. Eikelboom,Stephan Glund,Peter Verhamme,Richard A. Bernstein,Robert Dubiel,Menno V. Huisman,Elaine M. Hylek,Pieter W. Kamphuisen,Jörg Kreuzer,Jerrold H. Levy,Frank W. Sellke,Joachim Stangier,Thorsten Steiner,Bushi Wang,Chak Wah Kam,Jeffrey I. Weitz +17 more
TL;DR: Idarucizumab completely reversed the anticoagulant effect of dabigatran within minutes and normalized the test results in 88 to 98% of the patients, an effect that was evident within minutes.
Journal ArticleDOI
Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score
Sumeet Subherwal,Richard G. Bach,Anita Y. Chen,Brian F. Gage,Sunil V. Rao,L. Kristin Newby,Tracy Y. Wang,W. Brian Gibler,E. Magnus Ohman,Matthew T. Roe,Charles V. Pollack,Eric D. Peterson,Karen P. Alexander +12 more
TL;DR: The CRUSADE bleeding score quantifies risk for in-hospital major bleeding across all postadmission treatments, which enhances baseline risk assessment for NSTEMI care.
Journal ArticleDOI
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
Charles V. Pollack,Paul A. Reilly,Joanne van Ryn,John W. Eikelboom,Stephan Glund,Richard A. Bernstein,Robert Dubiel,Menno V. Huisman,Elaine M. Hylek,Elaine M. Hylek,Chak-Wah Kam,Chak-Wah Kam,Pieter Willem Kamphuisen,Jörg Kreuzer,Jerrold H. Levy,Gordon A. Royle,Frank W. Sellke,Joachim Stangier,Thorsten Steiner,Thorsten Steiner,Peter Verhamme,Bushi Wang,Laura Young,Jeffrey I. Weitz +23 more
TL;DR: In emergency situations, idarucizumab rapidly, durably, and safely reversed the anticoagulant effect of dabigatran.
Journal ArticleDOI
Association between hospital process performance and outcomes among patients with acute coronary syndromes.
Eric D. Peterson,Matthew T. Roe,Jyotsna Mulgund,Elizabeth R. DeLong,Barbara L. Lytle,Ralph G. Brindis,Sidney C. Smith,Charles V. Pollack,L. Kristin Newby,Robert A. Harrington,W. Brian Gibler,E. Magnus Ohman +11 more
TL;DR: A significant association between care process and outcomes was found, supporting the use of broad, guideline-based performance metrics as a means of assessing and helping improve hospital quality.
Journal ArticleDOI
Intravenous Platelet Blockade with Cangrelor during PCI
Deepak L. Bhatt,A. Michael Lincoff,C. Michael Gibson,Gregg W. Stone,Steven McNulty,Gilles Montalescot,Neal S. Kleiman,Shaun G. Goodman,Harvey D. White,Kenneth W. Mahaffey,Charles V. Pollack,Steven V. Manoukian,Petr Widimsky,Derek P. Chew,Fernando A. Cura,Ivan H Manukov,František Toušek,M. Zubair Jafar,Jaspal Arneja,Simona Skerjanec,Robert A. Harrington +20 more
TL;DR: The use of periprocedural cangrelor during PCI was not superior to placebo in reducing the primary end point, and the prespecified secondary end points of stent thrombosis and death were lower in the cang Relor group, with no significant increase in the rate of transfusion.